Evidence map›Paper›PMID 25847991›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy.

Laura C Matthews, Andrew A Berry, David J Morgan, Toryn M Poolman, Kerstin Bauer, Frederike Kramer, David G Spiller, Rachel V Richardson, Karen E Chapman, Stuart N Farrow and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. MedComm · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Network pharmacology andFrontiers in pharmacology · 2022
    Article
  13. Corticosteroid Receptors in Cardiac Health and Disease.Advances in experimental medicine and biology · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Investigating the Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Laura C MatthewsManchester Centre for Nuclear Hormone Research in Disease and Manchester Academic Health Sciences Centre, Institute of Human Development, Faculty of Medical and Human Sciences.
Andrew A BerryManchester Centre for Nuclear Hormone Research in Disease and Manchester Academic Health Sciences Centre, Institute of Human Development, Faculty of Medical and Human Sciences.
David J MorganManchester Centre for Nuclear Hormone Research in Disease and Manchester Academic Health Sciences Centre, Institute of Human Development, Faculty of Medical and Human Sciences.
Toryn M PoolmanManchester Centre for Nuclear Hormone Research in Disease and Manchester Academic Health Sciences Centre, Institute of Human Development, Faculty of Medical and Human Sciences.
Kerstin BauerInstitute for Comparative Molecular Endocrinology, University of Ulm, 89081 Ulm, Germany;
Frederike KramerLeibniz Institute for Age Research, Fritz Lipmann Institute, 07745 Jena, Germany;
David G SpillerFaculty of Life Sciences, and.
Rachel V RichardsonUniversity of Edinburgh, Edinburgh EH16 4TJ, United Kingdom;
Karen E ChapmanUniversity of Edinburgh, Edinburgh EH16 4TJ, United Kingdom;
Stuart N FarrowManchester Centre for Nuclear Hormone Research in Disease and Manchester Academic Health Sciences Centre, Institute of Human Development, Faculty of Medical and Human Sciences, GlaxoSmithKline, Stevenage SG1 2NY, United Kingdom; and.
Michael R NormanDivision of Medicine, University of Bristol, Bristol BS1 3NY, United Kingdom.
Andrew J K WilliamsonFaculty Institute of Cancer Sciences, University University of Manchester, Manchester M13 9PT, United Kingdom;
Anthony D WhettonFaculty Institute of Cancer Sciences, University University of Manchester, Manchester M13 9PT, United Kingdom;
Stephen S TaylorFaculty of Life Sciences, and.
Jan P TuckermannInstitute for Comparative Molecular Endocrinology, University of Ulm, 89081 Ulm, Germany; Leibniz Institute for Age Research, Fritz Lipmann Institute, 07745 Jena, Germany;
Michael R H WhiteFaculty of Life Sciences, and.
David W RayManchester Centre for Nuclear Hormone Research in Disease and Manchester Academic Health Sciences Centre, Institute of Human Development, Faculty of Medical and Human Sciences, david.w.ray@manchester.ac.uk.
Health Sciences Centre · CAUniversity of Edinburgh · GBUniversity of Manchester · GBGlaxoSmithKline (United Kingdom) · GBLeibniz Association · DELeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DEUniversität Ulm · DEUniversity of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K003097/1Cancer Research UKMedical Research Council MR/K015885/1Medical Research Council MR/L00254X/1Medical Research Council MR/L010240/1Medical Research Council MR/M008908/1Wellcome Trust
6 · The paper itself

Abstract

The glucocorticoid receptor (GR) is a member of the nuclear receptor superfamily, which controls programs regulating cell proliferation, differentiation, and apoptosis. We have identified an unexpected role for GR in mitosis. We discovered that specifically modified GR species accumulate at the mitotic spindle during mitosis in a distribution that overlaps with Aurora kinases. We found that Aurora A was required to mediate mitosis-driven GR phosphorylation, but not recruitment of GR to the spindle. GR was necessary for mitotic progression, with increased time to complete mitosis, frequency of mitotic aberrations, and death in mitosis observed following GR knockdown. Complementation studies revealed an essential role for the GR ligand-binding domain, but no clear requirement for ligand binding in regulating chromosome segregation. The GR N-terminal domain, and specifically phosphosites S203 and S211, were not required. Reduced GR expression results in a cell cycle phenotype, with isolated cells from mouse and human subjects showing changes in chromosome content over prolonged passage. Furthermore, GR haploinsufficient mice have an increased incidence of tumor formation, and, strikingly, these tumors are further depleted for GR, implying additional GR loss as a consequence of cell transformation. We identified reduced GR expression in a panel of human liver, lung, prostate, colon, and breast cancers. We therefore reveal an unexpected role for the GR in promoting accurate chromosome segregation during mitosis, which is causally linked to tumorigenesis, making GR an authentic tumor suppressor gene.

Indexed as

Chromosome SegregationGene Expression Regulation, NeoplasticAnimalsCell Transformation, NeoplasticHumansMiceMice, Mutant StrainsMitosisNeoplasmsProtein Structure, TertiaryReceptors, GlucocorticoidTumor Cells, CulturedTumor Suppressor ProteinsReceptors, GlucocorticoidTumor Suppressor ProteinsaneuploidycancerDNA damageglucocorticoid receptormitosis

Identifiers

PMID25847991
PMCPMC4418855
OpenAlexW2084104693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.